A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Eline M.P. Cremers, Théo de Witte, Liesbeth C. de Wreede, Diderik-Jan Eikema, Linda Köster, Anja van Biezen, Jürgen Finke, Gèrard Socié, Dietrich W. Beelen, Johan Maertens,

Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 27 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

= .04). This study illustrates the impact of RBCT and related parameters on HSCT-outcome. Patients with an expected prolonged survival after transplantation may benefit from early iron reduction therapy after transplantation.

References

30